CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences

Pharmacology, Biochemistry, and Behavior
E J BilskyL D Reid

Abstract

Cocaine and methylenedioxymethamphetamine (MDMA), two drugs self-administered by humans and laboratory animals, have previously been shown to produce conditioned place preferences (CPPs) among rats, an index of drug-reward relevant events. Both of these agents increase functional levels of dopamine that may be critical to their rewarding properties. Here, the effects of doses of CGS 10746B, an agent reported to attenuate the release of dopamine without occupying dopamine receptors, are assessed on cocaine and MDMA's ability to produce a CPP. CGS 10746B dose dependently blocked the establishment of a MDMA CPP. A 30 mg/kg dose of CGS 10746B, which completely blocked the MDMA CPP, also blocked the establishment of a cocaine CPP. Release of dopamine appears critical to the ability of these agents to establish a CPP.

References

Dec 1, 1992·Pharmacology, Biochemistry, and Behavior·D J Calcagnetti, M D Schechter
Jun 28, 1992·Annals of the New York Academy of Sciences·A G PhillipsH C Fibiger
Jan 1, 1991·Pharmacology, Biochemistry, and Behavior·M D Schechter
Mar 1, 1991·Pharmacology, Biochemistry, and Behavior·M D Schechter
Oct 1, 1991·Pharmacology, Biochemistry, and Behavior·D J Calcagnetti, M D Schechter
Aug 1, 1989·Pharmacology, Biochemistry, and Behavior·L D ReidC L Hubbell
May 30, 1989·European Journal of Pharmacology·E CarboniG Di Chiara
Jan 1, 1985·Pharmacology, Biochemistry, and Behavior·W B Mackey, D van der Kooy
Oct 1, 1986·Drug and Alcohol Dependence·P M BeardsleyL S Harris
Jan 1, 1987·Psychopharmacology·R J Lamb, R R Griffiths
Jan 1, 1988·Psychopharmacology·C B HubnerC Kornetsky
Aug 1, 1988·Pharmacology, Biochemistry, and Behavior·M D Schechter, J W Boja
Aug 1, 1994·European Journal of Pharmacology·M D Schechter, S M Meechan
Jun 1, 1994·Pharmacology, Biochemistry, and Behavior·R L PeltierS Schenk
Dec 1, 1954·Journal of Comparative and Physiological Psychology·J OLDS, P MILNER

❮ Previous
Next ❯

Citations

Dec 20, 2005·Psychopharmacology·José Manuel TrigoPatricia Robledo
Jun 2, 2005·Pharmacology, Biochemistry, and Behavior·Mariaelvina Sala, Daniela Braida
Jun 6, 2003·Neuroscience and Biobehavioral Reviews·Jon C Cole, Harry R Sumnall
Nov 13, 2001·Behavioural Brain Research·C ManzanedoJ Miñarro
Aug 23, 2002·Behavioural Brain Research·Gilberto GerraFrancesca Brambilla
Feb 15, 2007·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Manuel Daza-LosadaJose Miñarro
Jul 17, 2004·The European Journal of Neuroscience·Patricia RobledoRafael Maldonado
Mar 6, 2010·Annals of the New York Academy of Sciences·Ichiro SoraKazutaka Ikeda
Mar 8, 2013·Progress in Neuro-psychopharmacology & Biological Psychiatry·Andrés Ciudad-RobertsElena Escubedo
Jul 16, 2011·Pharmacology, Biochemistry, and Behavior·Wael M Y MohamedByron C Jones
Mar 17, 2015·Psychopharmacology·Linnet RamosIain S McGregor
Mar 1, 2015·Brain Research Bulletin·M A AguilarJ Miñarro
Oct 15, 2010·The International Journal of Neuropsychopharmacology·María Juliana OrejarenaPatricia Robledo
Feb 20, 2007·Biological Psychiatry·José Manuel TrigoRafael Maldonado
Jan 26, 2011·Journal of Psychopharmacology·Jessica Ruiz-MedinaOlga Valverde
Nov 30, 2005·Pharmacology, Biochemistry, and Behavior·Javier LluchJosé Miñarro
Mar 14, 2009·Journal of Psychopharmacology·B C JonesJ C Cassel
Jan 31, 2021·Pharmacology, Biochemistry, and Behavior·M L Shawn Bates, Keith A Trujillo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.